RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer

Carcinogenesis

Volumn 36, Issue 3, 2014, Pages 346-354

  Imaoka, Hiroki ^a   Toiyama, Yuji ^a   Saigusa, Susumu ^a   Kawamura, Mikio ^a   Kawamoto, Aya ^a   Okugawa, Yoshinaga ^a   Hiro, Junichiro ^a   Tanaka, Koji ^a   Inoue, Yasuhiro ^a   Mohri, Yasuhiko ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; RAC GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MGCRACGAP; TUMOR MARKER;

AGED; ARTICLE; CANCER CELL LINE; CANCER PROGNOSIS; CANCER RECURRENCE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; CELL MOTION; COHORT ANALYSIS; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR RECURRENCE;

AGED; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GTPASE-ACTIVATING PROTEINS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 84924434499     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu327     Document Type: Article

References (29)

1. Jemal, A. et al. (2010) Cancer statistics, 2010. CA. Cancer J. Clin., 60, 277-300.
2. Lurje, G. et al. (2007) Molecular prognostic markers in locally advanced colon cancer. Clin. Colorectal Cancer, 6, 683-690.
3. Andre, N. et al. (2005) Chemoradiotherapy for colorectal cancer. Gut, 54, 1194-1202.
4. Zhao, W.M. et al. (2005) MgcRacGAP controls the assembly of the contractile ring and the initiation of cytokinesis. Proc. Natl Acad. Sci. USA, 102, 13158-13163.
5. Kitamura, T. et al. (2001) Role of MgcRacGAP/Cyk4 as a regulator of the small GTPase Rho family in cytokinesis and cell differentiation. Cell Struct. Funct., 26, 645-651.
6. Hirose, K. et al. (2001) MgcRacGAP is involved in cytokinesis through associating with mitotic spindle and midbody. J. Biol. Chem., 276, 5821-5828.
7. Lee, J.S. et al. (2004) MgcRacGAP regulates cortical activity through RhoA during cytokinesis. Exp. Cell Res., 293, 275-282.
8. Jantsch-Plunger, V. et al. (2000) CYK-4: a Rho family GTPase activating protein (GAP) required for central spindle formation and cytokinesis. J. Cell Biol., 149, 1391-1404.
9. Toure,A. et al. (1998) MgcRacGAP, a new human GTPase-activating protein for Rac and Cdc42 similar to Drosophila RotundRacGAP gene product, is expressed in male germ cells. J. Biol. Chem., 273, 6019-6023.
10. Kawashima, T. et al. (2009) A Rac GTPase-activating protein, MgcRac-GAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors. Mol. Cell. Biol., 29, 1796-1813.
11. Darnell, J.E. Jr. (2002) Transcription factors as targets for cancer therapy. Nat. Rev. Cancer, 2, 740-749.
12. Sahai, E. (2005) Mechanisms of cancer cell invasion. Curr. Opin. Genet. Dev., 15, 87-96.
13. Jacquemet, G. et al. (2013) RCP-driven α5β1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1-IQGAP1 complex. J. Cell Biol., 202, 917-935.
14. Yamazaki, D. et al. (2009) Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene, 28, 1570-1583.
15. Vega, F.M. et al. (2008) Rho GTPases in cancer cell biology. FEBS Lett., 582, 2093-2101.
16. Sanz-Moreno, V. et al. (2008) Rac activation and inactivation control plasticity of tumor cell movement. Cell, 135, 510-523.
17. Zhang,Z. et al. (2014) IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways. Oncogene, 33, 3374-3382.
18. Fukata, M. et al. (2003) Roles of Rho-family GTPases in cell polarisation and directional migration. Curr. Opin. Cell Biol., 15, 590-597.
19. Zondag, G.C. et al. (2000) Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J. Cell Biol., 149, 775-782.
20. Saigusa, S. et al. (2015) Clinical significance of RacGAP1 expression at the invasive front of gastric cancer. Gastric Cancer, 18, 84-92.
21. Pliarchopoulou, K. et al. (2013) Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial. Cancer Chemother. Pharmacol., 71, 245-255.
22. Liang, Y. et al. (2013) Analysis of 20 genes at chromosome band 12q13:RACGAP1 and MCRS1 overexpression in nonsmall-cell lung cancer. Genes. Chromosomes Cancer, 52, 305-315.
23. Ke, H.L. et al. (2013) Expression of RACGAP1 in high grade meningiomas:a potential role in cancer progression. J. Neurooncol., 113, 327-332.
24. Wang, S.M. et al. (2011) Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Clin. Cancer Res., 17, 6040-6051.
25. Wong, S.C. et al. (2002) Expression of frizzled-related protein and Wntsignalling molecules in invasive human breast tumours. J. Pathol., 196, 145-153.
26. Grewal, S. et al. (2008) Implantation of the human embryo requires Rac1-dependent endometrial stromal cell migration. Proc. Natl Acad. Sci. USA, 105, 16189-16194.
27. Ma, X.J. et al. (2003) Gene expression profiles of human breast cancer progression. Proc. Natl Acad. Sci. USA, 100, 5974-5979.
28. Lu, K.H. et al. (2004) Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin. Cancer Res., 10, 3291-3300.
29. Baddi, L. et al. (2005) Adjuvant therapy in stage II colon cancer: current approaches. Oncologist, 10, 325-331.